Document and Entity Information
Document and Entity Information - $ / shares | 9 Months Ended | |
Sep. 30, 2018 | Nov. 02, 2018 | |
Details | ||
Registrant Name | INDEPENDENCE HOLDING COMPANY | |
Registrant CIK | 701,869 | |
SEC Form | 10-Q | |
Period End date | Sep. 30, 2018 | |
Fiscal Year End | --12-31 | |
Trading Symbol | ihc | |
Tax Identification Number (TIN) | 581,407,235 | |
Number of common stock shares outstanding | 14,795,106 | |
Filer Category | Accelerated Filer | |
Current with reporting | Yes | |
Small Business | true | |
Emerging Growth Company | false | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q3 | |
Entity Incorporation, State Country Name | Delaware | |
Entity Address, Address Line One | 96 CUMMINGS POINT ROAD | |
Entity Address, City or Town | STAMFORD | |
Entity Address, State or Province | CONNECTICUT | |
Entity Address, Postal Zip Code | 6,902 | |
City Area Code | 203 | |
Local Phone Number | 358-8000 | |
Entity Listing, Par Value Per Share | $ 1 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Investments | ||
Short-term Investments | $ 1,047 | $ 50 |
Securities Purchased under Agreements to Resell | 18,025 | 10,269 |
Debt Securities, Available-for-sale | 432,950 | 441,912 |
Equity Securities, FV-NI | 5,528 | 6,120 |
Other Investments | 17,511 | 18,547 |
Investments | 475,061 | 476,898 |
Cash and Cash Equivalents, at Carrying Value | 25,620 | 26,465 |
Premiums Receivable, Net | 29,100 | 21,950 |
Reinsurance Recoverables, Including Reinsurance Premium Paid | 371,540 | 380,593 |
Goodwill | 50,697 | 50,697 |
Other Assets | 83,928 | 84,020 |
Assets | 1,035,946 | 1,040,623 |
Liabilities | ||
Liability for Claims and Claims Adjustment Expense | 158,168 | 168,683 |
Liability for Future Policy Benefits | 209,588 | 214,766 |
Deposit Contracts, Liabilities | 141,685 | 143,537 |
Unearned Premiums | 9,452 | 6,666 |
Policyholder Funds | 10,900 | 10,402 |
Reinsurance Payable | 4,855 | 3,808 |
Other Liabilities | 53,752 | 56,453 |
Liabilities | 588,400 | 604,315 |
Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount | 2,146 | 2,065 |
TOTAL LIABILITIES AND EQUITY | 1,035,946 | 1,040,623 |
STOCKHOLDERS' EQUITY: | ||
Preferred Stock, Value, Issued | 0 | 0 |
Common Stock, Value, Issued | 18,625 | 18,625 |
Paid-in capital | 125,279 | 124,538 |
Accumulated Other Comprehensive Income (Loss), Net of Tax | (11,963) | (4,598) |
Treasury stock, at cost; 3,825,786 and 3,735,173 shares | 66,918 | 63,404 |
Retained Earnings (Accumulated Deficit) | 377,848 | 356,383 |
TOTAL IHC STOCKHOLDERS' EQUITY | 442,871 | 431,544 |
Stockholders' Equity Attributable to Noncontrolling Interest | 2,529 | 2,699 |
TOTAL EQUITY | $ 445,400 | $ 434,243 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets - Parenthetical - $ / shares | Sep. 30, 2018 | Dec. 31, 2017 |
Details | ||
Preferred Stock, Par or Stated Value Per Share | $ 1 | $ 1 |
Preferred Stock, Shares Authorized | 100,000 | 100,000 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Common Stock, Par or Stated Value Per Share | $ 1 | $ 1 |
Common Stock, Shares Authorized | 23,000,000 | 23,000,000 |
Common Stock, Shares, Issued | 18,625,458 | 18,625,458 |
Common Stock, Shares, Outstanding | 14,799,672 | 14,890,285 |
Treasury Stock, Shares | 3,825,786 | 3,735,173 |
Condensed Consolidated Income S
Condensed Consolidated Income Statement - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Revenues | ||||
Premiums Earned, Net | $ 81,757 | $ 75,639 | $ 238,583 | $ 210,507 |
Net Investment Income | 3,611 | 4,403 | 10,214 | 12,414 |
Insurance Commissions and Fees | 4,397 | 2,634 | 14,193 | 11,556 |
Other Income | 153 | 361 | 472 | 2,365 |
Gain (Loss) on Investments | 17 | 715 | (335) | 987 |
Revenues | 89,935 | 83,752 | 263,127 | 237,829 |
Operating Expenses | ||||
Policyholder Benefits and Claims Incurred, Net | 36,011 | 33,536 | 105,619 | 103,071 |
Selling, General and Administrative Expense | 41,021 | 42,337 | 126,057 | 115,404 |
Benefits, Losses and Expenses | 77,032 | 75,873 | 231,676 | 218,475 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 12,903 | 7,879 | 31,451 | 19,354 |
Income Tax Expense (Benefit) | 2,860 | 2,666 | 7,518 | (5,175) |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | 10,043 | 5,213 | 23,933 | 24,529 |
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest | 59 | (32) | 99 | 4 |
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest | 49 | 16 | 181 | 29 |
Net Income (Loss) Attributable to Parent | $ 9,935 | $ 5,229 | $ 23,653 | $ 24,496 |
Earnings Per Share, Basic | $ 0.67 | $ 0.35 | $ 1.60 | $ 1.53 |
Weighted Average Number of Shares Outstanding, Basic | 14,795 | 14,965 | 14,808 | 15,999 |
Earnings Per Share, Diluted | $ 0.66 | $ 0.34 | $ 1.57 | $ 1.50 |
Weighted Average Number of Shares Outstanding, Diluted | 15,109 | 15,274 | 15,104 | 16,287 |
Condensed Consolidated Statemen
Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Details | ||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 10,043 | $ 5,213 | $ 23,933 | $ 24,529 |
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax | ||||
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax | (925) | 250 | (8,908) | 7,219 |
Other Comprehensive Income (Loss), Securities, Available-for-sale, Tax | (199) | 90 | (1,893) | 2,599 |
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax | (726) | 160 | (7,015) | 4,620 |
Other Comprehensive Income (Loss), Net of Tax | (726) | 160 | (7,015) | 4,620 |
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | 9,317 | 5,373 | 16,918 | 29,149 |
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | ||||
Net Income (Loss) Attributable to Noncontrolling Interest | 108 | (16) | 280 | 33 |
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | 108 | (16) | 280 | 33 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $ 9,209 | $ 5,389 | $ 16,638 | $ 29,116 |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | AOCI Attributable to Parent | Treasury Stock | Retained Earnings | Parent | Noncontrolling Interest |
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2017 | $ 434,243 | $ 18,625 | $ 124,538 | $ (4,598) | $ (63,404) | $ 356,383 | $ 431,544 | $ 2,699 |
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest | 23,752 | 23,653 | 23,653 | 99 | ||||
Other Comprehensive Income (Loss), Net of Tax | (7,015) | (7,015) | (7,015) | 0 | ||||
Treasury Stock, Value, Acquired, Cost Method | (3,817) | (3,817) | (3,817) | 0 | ||||
Dividends, Common Stock, Cash | (2,222) | (2,222) | (2,222) | 0 | ||||
Distributions to noncontrolling interests | (172) | 0 | (172) | |||||
Sharebased Compensation Effect On Stockholders Equity | 1,044 | 741 | 303 | 1,044 | 0 | |||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2018 | 445,400 | 18,625 | 125,279 | (11,963) | (66,918) | 377,848 | 442,871 | 2,529 |
Other Comprehensive Income (Loss), Net of Tax | (726) | |||||||
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2018 | 445,400 | $ 18,625 | $ 125,279 | (11,963) | $ (66,918) | 377,848 | 442,871 | 2,529 |
Cumulative Effect of New Accounting Principle in Period of Adoption | $ (413) | $ (350) | $ 34 | $ (316) | $ (97) |
Condensed Consolidated Statem_3
Condensed Consolidated Statement of Stockholders' Equity - Parenthetical | 9 Months Ended |
Sep. 30, 2018$ / shares | |
Details | |
Common Stock, Dividends, Per Share, Declared | $ 0.15 |
Condensed Consolidated Statem_4
Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
CASH FLOWS PROVIDED BY (USED BY) OPERATING ACTIVITIES: | ||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ 23,933 | $ 24,529 |
Net Cash Provided by (Used in) Operating Activities | 20,638 | 20,206 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | (1,786) | 8,731 |
Adjustments to reconcile net income to net change in cash from | ||
Deferred Policy Acquisition Costs, Amortization Expense | 681 | 269 |
Gain (Loss) on Investments, Excluding Other than Temporary Impairments | (335) | 987 |
Income (Loss) from Equity Method Investments | (976) | 1,412 |
Depreciation, Depletion and Amortization, Nonproduction | 1,953 | 1,379 |
Deferred Income Tax Expense (Benefit) | 3,535 | 1,853 |
Other Noncash Income (Expense) | (4,808) | (4,852) |
Increase (Decrease) in Operating Capital | ||
Increase (Decrease) in Insurance Liabilities | (12,181) | (83,750) |
Increase (Decrease) in Premiums Receivable | 7,150 | (10,218) |
Increase (Decrease) in Reinsurance Recoverable | (9,053) | (57,094) |
Change in Claim Fund Balances | 294 | 8,463 |
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | 1,031 | (8,604) |
Increase (Decrease) in Other Operating Assets and Liabilities, Net | 6,630 | (6,302) |
Net Cash Provided by (Used in) Investing Activities | ||
Payments for (Proceeds from) Short-term Investments | 999 | (6,849) |
Proceeds from (Payments for) Securities Purchased under Agreements to Resell | (7,756) | 8,365 |
Proceeds from Sale of Available-for-sale Securities, Equity | 698 | 0 |
Proceeds from Sale of Debt Securities, Available-for-sale | 55,338 | 158,062 |
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | 21,992 | 16,841 |
Payments to Acquire Debt Securities, Available-for-sale | 79,374 | 145,444 |
Payments to Acquire Businesses, Net of Cash Acquired | 0 | 12,323 |
Proceeds from Equity Method Investment, Distribution, Return of Capital | 0 | 5,246 |
Payments to Acquire Other Investments | 0 | 602 |
Other investing activities | 3,709 | 565 |
Net Cash Provided by (Used in) Investing Activities | (13,810) | 36,429 |
Net Cash Provided by (Used in) Financing Activities | ||
Payments for Repurchase of Common Stock | 3,943 | 44,290 |
Net Change Annuities and Investment Certificates | (1,033) | (1,359) |
Payments of Ordinary Dividends, Common Stock | 3,710 | 1,927 |
Proceeds from (Payments for) Other Financing Activities | 72 | (328) |
Net Cash Provided by (Used in) Financing Activities | (8,614) | (47,904) |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance | 32,197 | 23,718 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance | $ 30,411 | $ 32,449 |
Organization, Consolidation, Ba
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies | Note 1. Organization, Consolidation, Basis of Presentation and Accounting Policies (A) Business and Organization (B) Basis of Presentation The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and nine months ended September 30, 2018 are not necessarily indicative of the results to be anticipated for the entire year. (C) Reclassifications Certain amounts in prior year’s consolidated financial statements and Notes thereto have been reclassified to conform to the 2018 presentation primarily as a result of new accounting principles adopted in the current year. impairment assessment of equity securities without readily determinable fair values and requires changes in disclosure requirements. The amendments in this guidance were applied by means of a cumulative-effect adjustment of $340,000 credit to retained earnings as of January 1, 2018. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) will be applied prospectively to equity investments that existed as of January 1, 2018. The adoption of this guidance did not have a material effect on the Company’s Consolidated Balance Sheet or IHC’s stockholders’ equity. In May 2014, the FASB issued revenue recognition guidance for entities that either enter into contracts with customers to transfer goods or services or enter into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards such as insurance contracts or lease contracts. The amendment provides specific steps that an entity should apply in order to achieve its main objective which is recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Substantially all of the Company’s revenue sources are excluded from the scope of the standard. For those revenue sources within the scope of the standard (included in the Fee income line of the Condensed Consolidated Statement of Income), there were no material changes in the timing or measurement of revenues. The amendments in this guidance were applied retrospectively with a cumulative effect adjustment on January 1, 2018, and as such, the Company recorded $552,000 of contract assets and $1,094,000 of deferred revenues, which are included on the Condensed Consolidated Balance Sheet in other assets and accounts payable, accruals and other liabilities. The overall net impact on retained earnings was a charge of $306,000, after the effects of taxes and noncontrolling interests. Recently Issued Accounting Standards Not Yet Adopted In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. The amendments in this guidance are effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In August 2018, the FASB issued guidance to improve the effectiveness of disclosures in the notes to financial statements regarding fair value measurements. The amendments in this guidance are effective for all entities for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year. Certain amendments should be applied prospectively for the most recent interim or annual period presented in the initial fiscal year of adoption while other amendments should be applied retrospectively to all periods presented upon the effective date. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In July 2018, the FASB issued guidance to simplify several aspects of accounting for nonemployee share-based compensation. The amendments in this guidance are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In March 2017, the FASB issued guidance requiring premium amortization on callable debt securities to be amortized to the earliest call date to more closely align the amortization period with expectations incorporated in market pricing of the underlying securities. The amendments in this guidance should be applied using a modified retrospective approach for annual periods beginning after December 15, 2018, including interim periods within those periods. Additional disclosures are required in the period of adoption. Early adoption is permitted. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In January 2017, the FASB issued guidance to simplify the test for goodwill impairment by eliminating Step 2 in the goodwill impairment test. Instead, under the amendments in this guidance, an entity should perform its annual or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The amendments in this guidance are effective for public business entities for annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. For public entities that are SEC filers, the amendments in this guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Early adoption is permitted for fiscal years beginning after December 15, 2018. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In February 2016, the FASB issued guidance that requires lessees to recognize the assets and liabilities that arise from leases, including operating leases, on the statement of financial position. The amendments in this guidance are effective for fiscal years beginning after December 31, 2018, including interim periods within those fiscal years. In July 2018, the FASB issued additional guidance that allows entities the option to either recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption or to use a modified retrospective approach. The Company is in the process of analyzing its lease portfolio. This process includes the evaluation of policies, processes and internal controls that will be required to comply with this new guidance. The Company plans to elect the practical expedients permitted within the new standard, which among other things, allows us to carryforward the historical lease classification. In addition, the Company plans to select the new transition method and apply the new lease requirements in the period of adoption without adjustment to the financial statements for periods prior to adoption. The Company expects the adoption of this new standard to result in an increase on its consolidated balance sheet for right-of-use assets and corresponding lease liabilities. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated results of operations or cash flows. |
Earnings Per Share _Text Block_
Earnings Per Share [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Earnings Per Share | Note 2. Income Per Common Share Diluted income per share was computed using the treasury stock method and includes incremental common shares, primarily from the dilutive effect of share-based payment awards, amounting to 314,000 and 296,000 shares for the three and nine months ended September 30, 2018, respectively, and 309,000 and 288,000 shares for the three months and nine months ended September 30, 2017. |
Cash and Cash Equivalents Discl
Cash and Cash Equivalents Disclosure | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Cash and Cash Equivalents Disclosure | Note 3. Cash, Cash Equivalents and Restricted Cash September 30, 2018 2017 Cash and cash equivalents $ 25,620 $ 26,565 Restricted cash included in other assets 4,791 5,884 Total cash, cash equivalents and restricted cash $ 30,411 $ 32,449 Restricted cash includes insurance premiums collected from insureds that are pending remittance to insurance carriers and/or payment of insurance claims and commissions to third party administrators. These amounts are required to be set aside by contractual agreements with the insurance carriers and are included in other assets on the Condensed Consolidated Balance Sheets. |
Investments in Debt and Marketa
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure | Note 4. Investment Securities The cost (amortized cost with respect to certain fixed maturities), gross unrealized gains, gross unrealized losses and fair value of fixed maturities available-for-sale are as follows for the periods indicated (in thousands): September 30, 2018 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 200,252 $ 537 $ (6,882) $ 193,907 CMOs – residential (1) 6,266 2 (388) 5,880 U.S. Government obligations 48,857 - (730) 48,127 Agency MBS – residential (2) 6 - - 6 GSEs (3) 9,566 - (347) 9,219 States and political subdivisions 173,109 129 (7,186) 166,052 Foreign government obligations 4,081 - (119) 3,962 Redeemable preferred stocks 5,970 - (173) 5,797 Total fixed maturities $ 448,107 $ 668 $ (15,825) $ 432,950 December 31, 2017 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 148,996 $ 298 $ (2,847) $ 146,447 CMOs - residential (1) 6,857 - (180) 6,677 U.S. Government obligations 85,510 - (396) 85,114 Agency MBS - residential (2) 14 - - 14 GSEs (3) 9,887 - (205) 9,682 States and political subdivisions 182,664 598 (3,619) 179,643 Foreign government obligations 4,227 13 (90) 4,150 Redeemable preferred stocks 10,006 179 - 10,185 Total fixed maturities $ 448,161 $ 1,088 $ (7,337) $ 441,912 (1) (2) (3) The amortized cost and fair value of fixed maturities available-for-sale at September 30, 2018, by contractual maturity, are shown below (in thousands). Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. AMORTIZED FAIR COST VALUE Due in one year or less $ 27,898 $ 27,734 Due after one year through five years 174,430 170,503 Due after five years through ten years 138,042 132,762 Due after ten years 91,899 86,846 Fixed maturities with no single maturity date 15,838 15,105 $ 448,107 $ 432,950 The following tables summarize, for all fixed maturities available-for-sale in an unrealized loss position, the aggregate fair value and gross unrealized loss by length of time those securities that have continuously been in an unrealized loss position for the periods indicated (in thousands): September 30, 2018 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 98,623 $ 2,949 $ 88,261 $ 3,933 $ 186,884 $ 6,882 CMOs - residential 859 57 5,106 331 5,965 388 U.S. Government obligations 39,740 328 8,388 402 48,128 730 GSEs - - 9,318 347 9,318 347 States and political subdivisions 59,619 1,753 99,307 5,433 158,926 7,186 Foreign government obligations 1,145 12 2,816 107 3,961 119 Redeemable preferred stocks 5,797 173 - - 5,797 173 Fixed maturities in an unrealized loss position $ 205,783 $ 5,272 $ 213,196 $ 10,553 $ 418,979 $ 15,825 Number of fixed maturities in an unrealized loss position 99 96 195 December 31, 2017 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 85,642 $ 1,250 $ 44,640 $ 1,597 $ 130,282 $ 2,847 CMOs - residential 1,381 45 5,237 135 6,618 180 U.S. Government obligations 75,811 198 9,302 198 85,113 396 GSEs - - 9,669 205 9,669 205 States and political subdivisions 83,682 1,348 66,617 2,271 150,299 3,619 Foreign government obligations 2,959 90 - - 2,959 90 Fixed maturities in an unrealized loss position $ 249,475 $ 2,931 $ 135,465 $ 4,406 $ 384,940 $ 7,337 Number of fixed maturities in an unrealized loss position 60 76 136 Substantially all of the unrealized losses on fixed maturities available-for-sale at September 30, 2018 and December 31, 2017 relate to investment grade securities and are attributable to changes in market interest rates. Because the Company does not intend to sell, nor is it more likely than not that the Company will have to sell such investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider these investments to be other-than-temporarily impaired at September 30, 2018 Net investment gains (losses) are as follows for periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Realized gains (losses): Fixed maturities available-for-sale $ (247) $ 719 $ (442) $ 1,062 Equity securities (2) - (7) - Total realized gains (losses) on debt and equity securities (249) 719 (449) 1,062 Unrealized gains (losses) on equity securities 266 (4) 114 (76) Gains (losses) on debt and equity securities 17 715 (335) 986 Gains (losses) on other investments - - - 1 Net investment gains (losses) $ 17 $ 715 $ (335) $ 987 For the three months and nine months ended September 30, 2018, the Company realized gross gains of $130,000 and $449,000, respectively, and gross losses of $377,000 and $891,000, respectively, from sales, maturities and prepayments of fixed maturities available-for-sale. For the three months and nine months ended September 30, 2017, the company realized gross gains of $780,000 and $2,119,000, respectively, and gross losses of $61,000 and $1,057,000, respectively, from sales, maturities and prepayments of fixed maturities available for sale. Other-Than-Temporary Impairment Evaluations We recognize other-than-temporary impairment losses in earnings in the period that we determine: 1) we intend to sell the security; 2) it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis; or 3) the security has a credit loss. Any non-credit portion of the other-than-temporary impairment loss is recognized in other comprehensive income (loss). See Note 1F(iv) to the Consolidated Financial Statements in the 2017 Annual Report on Form 10-K for further discussion of the factors considered by management in its regular review to identify and recognize other-than-temporary impairments on fixed maturities available-for-sale. The Company did not recognize any other-than-temporary impairments on fixed maturities available-for-sale securities in the first nine months of 2018 or 2017. |
Fair Value Disclosures _Text Bl
Fair Value Disclosures [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Fair Value Disclosures | Note 5. Fair Value Disclosures For all financial and non-financial assets and liabilities accounted for at fair value on a recurring basis, the Company utilizes valuation techniques based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market expectations. These two types of inputs create the following fair value hierarchy: Level 1 Level 2 Level 3 The following section describes the valuation methodologies we use to measure different assets at fair value. Fixed maturities available-for-sale: Fixed maturities available-for-sale included in Level 2 are comprised of our portfolio of government securities, agency mortgage-backed securities, corporate fixed income securities, foreign government obligations, collateralized mortgage obligations, municipals and GSEs that were priced with observable market inputs. Level 3 debt securities consist of municipal tax credit strips. The valuation method used to determine the fair value of municipal tax credit strips is the present value of the remaining future tax credits (at the original issue discount rate) as presented in the redemption tables in the Municipal Prospectuses. This original issue discount is accreted into income on a constant yield basis over the term of the debt instrument. Further, we retain independent pricing vendors to assist in valuing certain instruments. Equity securities: The following tables present our financial assets measured at fair value on a recurring basis for the periods indicated (in thousands): September 30, 2018 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 193,907 $ - $ 193,907 CMOs - residential - 5,880 - 5,880 US Government obligations - 48,127 - 48,127 Agency MBS - residential - 6 - 6 GSEs - 9,219 - 9,219 States and political subdivisions - 164,300 1,752 166,052 Foreign government obligations - 3,962 - 3,962 Redeemable preferred stocks 5,797 - - 5,797 Total fixed maturities 5,797 425,401 1,752 432,950 Equity securities: Common stocks 2,691 - - 2,691 Nonredeemable preferred stocks 2,837 - - 2,837 Total equity securities 5,528 - - 5,528 Total Financial Assets $ 11,325 $ 425,401 $ 1,752 $ 438,478 December 31, 2017 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 146,447 $ - $ 146,447 CMOs - residential - 6,677 - 6,677 US Government obligations - 85,114 - 85,114 Agency MBS - residential - 14 - 14 GSEs - 9,682 - 9,682 States and political subdivisions - 177,767 1,876 179,643 Foreign government obligations - 4,150 - 4,150 Redeemable preferred stocks 10,185 - - 10,185 Total fixed maturities 10,185 429,851 1,876 441,912 Equity securities: Common stocks 2,490 - - 2,490 Nonredeemable preferred stocks 3,630 - - 3,630 Total equity securities 6,120 - - 6,120 Total Financial Assets $ 16,305 $ 429,851 $ 1,876 $ 448,032 It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. The Company did not transfer any securities between Level 1, Level 2 or Level 3 in either 2018 or 2017. The following table presents the changes in fair value of our Level 3 financial assets for the periods indicated (in thousands): Three Months Ended September 30, 2018 2017 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,794 $ 1,794 $ 1,956 $ 1,956 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (8) (8) Repayments and amortization of fixed maturities (34) (34) (31) (31) Sales - - - - Balance at end of period $ 1,752 $ 1,752 $ 1,917 $ 1,917 Nine Months Ended September 30, 2018 2017 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,876 $ 1,876 $ 2,033 $ 2,033 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (23) (23) (26) (26) Repayments and amortization of fixed maturities (101) (101) (90) (90) Sales - - - - Balance at end of period $ 1,752 $ 1,752 $ 1,917 $ 1,917 The following table provides carrying values, fair values and classification in the fair value hierarchy of the Company’s financial instruments, that are not carried at fair value but are subject to fair value disclosure requirements, for the periods indicated (in thousands): September 30, 2018 December 31, 2017 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 1,047 $ - $ 1,047 $ 50 $ - $ 50 FINANCIAL LIABILITIES: Funds on deposit $ - $ 141,813 $ 141,685 $ - $ 143,702 $ 143,537 The following methods and assumptions were used to estimate the fair value of the financial instruments that are not carried at fair value in the Condensed Consolidated Financial Statements: Short-term Investments Investments with original maturities of 91 days to one year are considered short-term investments and are carried at cost, which approximates fair value. Funds on Deposit The Company has two types of funds on deposit. The first type is credited with a current market interest rate, resulting in a fair value which approximates the carrying amount. The second type carries fixed interest rates which are higher than current market interest rates. The fair value of these deposits was estimated by discounting the payments using current market interest rates. The Company's universal life policies are also credited with current market interest rates, resulting in a fair value which approximates the carrying amount. Both types of funds on deposit are included in Level 2 of the fair value hierarchy. |
Variable Interest Entity Disclo
Variable Interest Entity Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Variable Interest Entity Disclosure | Note 6. Other Investments, Including Variable Interest Entities Included in other investments is our investment in Ebix Health Exchange which administers various lines of health insurance for IHC’s insurance subsidiaries. The carrying value of the Company’s equity investment in Ebix Health Exchange is $6,973,000 and $8,188,000 at September 30, 2018 and December 31, 2017, respectively. The Company recorded $(445,000) and $(1,216,000), respectively, of equity income (loss) from its investment for the three months and nine months ended September 30, 2018 and $(19,000) and $228,000, respectively, of equity income (loss) for the same periods ended September 30, 2017. At September 30, 2018 and December 31, 2017, the Company’s Consolidated Balance Sheets include $1,886,000 and $1,859,000, respectively, of notes and other amounts receivable from Ebix Health Exchange and include $1,086,000 and $1,139,000, respectively, of administrative fees and other expenses payable to Ebix Health Exchange, which are included in other assets and accounts payable, accruals and other liabilities, respectively. The Company’s Consolidated Statements of Income include administrative fee expenses to Ebix Health Exchange which are included in selling, general and administrative expenses of $1,796,000 and $6,269,000 for the three and nine months ended September 30, 2018, respectively, and $2,613,000 and $8,017,000, respectively, for the same periods of 2017. Variable Interest Entities The Company has a minority interest in certain limited partnerships that we have determined to be Variable Interest Entities (“VIEs”). The aforementioned VIEs are not required to be consolidated in the Company’s condensed consolidated financial statements as we are not the primary beneficiary since we do not have the power to direct the activities that most significantly impact the VIEs’ economic performance. The Company will periodically reassess whether we are the primary beneficiary in any of these investments. The reassessment process will consider whether we have acquired the power to direct the most significant activities of the VIE through changes in governing documents or other circumstances. Our maximum loss exposure is limited to our combined $4,131,000 carrying value in these equity investments which is included in other investments in the Condensed Consolidated Balance Sheet as of September 30, 2018. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Goodwill and Intangible Assets Disclosure | Note 7. Goodwill and Other Intangible Assets The gross carrying amounts of these other intangible assets are as follows for the periods indicated (in thousands): September 30, 2018 December 31, 2017 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 17,253 $ 13,096 $ 17,253 $ 12,140 Domain 1,000 200 1,000 125 Software systems 780 169 780 76 Total finite-lived $ 19,033 $ 13,465 $ 19,033 $ 12,341 September 30, December 31, 2018 2017 Indefinite-lived Intangible Assets: Insurance licenses $ 7,977 $ 7,977 Total indefinite-lived $ 7,977 $ 7,977 |
Income Tax Disclosure _Text Blo
Income Tax Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Income Tax Disclosure | Note 8. Income Taxes The provisions for income taxes shown in the Condensed Consolidated Statements of Income were computed by applying the effective tax rate expected to be applicable for the reporting periods. In 2017, President Trump signed tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code, including, but not limited to, reducing the Federal corporate income tax rate to 21%. As a result of IHC’s June 30 fiscal tax year, the Tax Act subjects IHC to a blended tax rate of 28% for its fiscal tax year ended June 30, 2018. Other differences between the Federal statutory income tax rate and the Company’s effective income tax rate are principally from the dividends received deduction and tax exempt interest income, state and local income taxes, and compensation related tax provisions. |
Liability for Future Policy Ben
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Liability for Future Policy Benefits and Unpaid Claims Disclosure | Note 9. Policy Benefits and Claims Policy benefits and claims is the liability for unpaid loss and loss adjustment expenses. It is comprised of unpaid claims and estimated IBNR reserves. Summarized below are the changes in the total liability for policy benefits and claims for the periods indicated (in thousands). Nine Months Ended September 30, 2018 2017 Balance at beginning of year $ 168,683 $ 219,113 Less: reinsurance recoverable 42,136 88,853 Net balance at beginning of year 126,547 130,260 Amount incurred, related to: Current year 127,544 114,795 Prior years (19,152) (9,236) Total incurred 108,392 105,559 Amount paid, related to: Current year 65,380 52,822 Prior years 49,916 56,452 Total paid 115,296 109,274 Net balance at end of period 119,643 126,545 Plus: reinsurance recoverable 38,525 43,002 Balance at end of period $ 158,168 $ 169,547 Since unpaid loss and loss adjustment expenses are estimates, actual losses incurred may be more or less than the Company’s previously developed estimates and is referred to as either unfavorable or favorable development, respectively. The overall net favorable development of $19,152,000 in 2018 related to prior years consists of favorable developments of $9,729,000 in the Specialty Health reserves, $7,862,000 in the group disability reserves, $1,346,000 in the other individual life, annuities and other reserves, and $215,000 in Medical Stop-Loss reserves. Specialty Health had net favorable development primarily from: (i) the release of reserves due to emerging favorable experience on hospital indemnity plan business written in 2017 on increased sales volume of this product; (ii) short-term medical business as inventory levels decreased during 2018 and paid claim activity was below the levels anticipated; and, (iii) favorable development in other lines of Specialty Health business. Group disability had net favorable development primarily as a result of a lower number of expected claims and greater number of expected terminations in our LTD business. The overall net favorable development of $9,236,000 in 2017 related to prior years primarily consists of favorable developments of $2,420,000 in the Medical Stop-Loss reserves, $5,406,000 in the group disability reserves, and $2,714,000 in the other individual life, annuities and other reserves, partially offset by an unfavorable development of $1,304,000 in Specialty Health reserves. Included in the preceding rollforward of the Company’s liability for policy benefits and claims are the policy benefits and claims activity associated with the Company’s health insurance lines. These are embedded within the Specialty Health segment. The table below summarizes the components of the change in the liability for policy benefits and claims that are specific to health insurance claims for the periods indicated (in thousands). Specialty Health Segment Health Insurance Claims Nine Months Ended September 30, 2018 2017 Balance at beginning of year $ 32,904 $ 27,183 Less: reinsurance recoverable 762 1,179 Net balance at beginning of year 32,142 26,004 Amount incurred, related to: Current year 37,099 40,836 Prior years (8,266) 1,144 Total incurred 28,833 41,980 Amount paid, related to: Current year 14,880 13,528 Prior years 19,507 23,797 Total paid 34,387 37,325 Net balance at end of period 26,588 30,659 Plus: reinsurance recoverable 865 814 Balance at end of period $ 27,453 $ 31,473 The liability for the IBNR plus expected development on reported claims associated with the Company’s health insurance claims is $27,453,000 at September 30, 2018. |
Stockholders' Equity Note Discl
Stockholders' Equity Note Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Stockholders' Equity Note Disclosure | Note 10. Stockholders’ Equity Treasury Stock In 2018, the Company repurchased 129,521 shares of its common stock for an aggregate cost of $3,817,000. In 2018 all shares were purchased in the open market. In 2017, the Company repurchased 2,211,629 shares of its common stock for an aggregate cost of $44,442,000. Of that amount, 703,000 shares were repurchased in private transactions for an aggregate cost of $13,975,000, 1,385,118 shares were repurchased for an aggregate cost of $27,702,000 pursuant to the terms of a tender offer; and the remaining shares were repurchased in the open market. Accumulated Other Comprehensive Income (Loss) Other comprehensive income (loss) includes the after-tax net unrealized gains and losses on investment securities available-for-sale, including the subsequent increases and decreases in fair value of available-for-sale securities previously impaired and the non-credit related component of other-than-temporary impairments of fixed maturities. In 2018, investment securities available-for-sale consist of only fixed maturities. Prior to January 1, 2018, the Company classified certain equity securities as available-for-sale. Changes to the fair value of those equity securities classified as available-for-sale were recorded in other comprehensive income (loss) for the corresponding periods in 2017 and prior. Upon the adoption of new accounting guidance on January 1, 2018, the Company: (i) recorded a cumulative-effect adjustment to reclassify the existing amounts reported in accumulated other comprehensive income on that date for equity securities previously classified as available-for-sale, to retained earnings; and (ii) recorded the subsequent changes in the fair value of those equity securities in net income. Changes in the balances of accumulated other comprehensive loss, shown net of taxes, for the periods indicated are as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Beginning balance $ (11,237) $ (2,504) $ (4,598) $ (6,964) Cumulative-effect of new accounting principles - - (350) - Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications (922) 627 (7,364) 5,305 Amounts reclassified from accumulated OCI 196 (467) 349 (685) Net other comprehensive income (loss) (726) 160 (7,015) 4,620 Ending balance $ (11,963) $ (2,344) $ (11,963) $ (2,344) Presented below are the amounts reclassified out of accumulated other comprehensive income (loss) and recognized in earnings for each of the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ (247) $ 719 $ (442) $ 1,062 Income (loss) before income tax (247) 719 (442) 1,062 Tax effect (51) 252 (93) 377 Net income (loss) $ (196) $ 467 $ (349) $ 685 |
Compensation and Employee Benef
Compensation and Employee Benefit Plans [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Compensation and Employee Benefit Plans | Note 11. Share-Based Compensation Under the terms of IHC’s share-based compensation plans: (i) the exercise price of an option may not be less than the fair market value of an IHC share on the grant date, and the terms of an option may not exceed 10 years from the grant date; and (ii) the exercise price of a SAR may not be less than the fair market value of an IHC share on the grant date and SAR terms may not exceed 10 years from the date of grant. The fair value of an option award is estimated on the date of grant using the Black-Scholes option valuation model. In general, the vesting period for an option grant is 3 years. Restricted share units are valued at the quoted market price of the shares at the date of grant and generally vest over 3 years. Compensation costs for options and restricted share units are recognized over the stated vesting periods on a straight-line basis. The fair value of a SAR is calculated using the Black-Scholes valuation model at the grant date and each subsequent reporting period until settlement. Compensation cost is based on the proportionate amount of the requisite service that has been rendered to date. Once fully vested, changes in the fair value of a SAR continue to be recognized as compensation expense in the period of the change until settlement. The Company accounts for forfeitures of share-based compensation awards in the period that they occur. At September 30, 2018, there were 846,300 shares available for future stock-based compensation grants under IHC’s stock incentive plans. The following table summarizes share-based compensation expense, which is included in selling, general and administrative expenses on the Condensed Consolidated Statements of Income, applicable to the IHC plans, by award type for each of the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 IHC’s Share-based Compensation Plan: Stock options $ 189 $ 36 $ 558 $ 106 Restricted stock units 39 23 129 81 SARs 93 305 218 359 Share-based compensation expense, pre-tax 321 364 905 546 Tax benefits 86 145 281 218 Share-based compensation expense, net $ 235 $ 219 $ 624 $ 328 Stock Options The IHC’s stock option activity during 2018 was as follows: Shares Weighted- Average Under Option Exercise Price December 31, 2017 692,380 $ 16.62 Granted 13,000 31.30 Exercised (36,433) 9.79 September 30, 2018 668,947 $ 17.28 2018 2017 Weighted-average risk-free interest rate 2.64% 1.71% Expected annual dividend rate per share 0.95% 0.79% Expected volatility factor of the Company's common stock 35.80% 37.57% Weighted-average expected term of options 4.5 years 4.5 years In 2018, IHC received $357,000 in cash from the exercise of stock options with an aggregate intrinsic value of $886,000 and recognized $165,000 of tax benefits. In 2017, IHC received no cash from the exercise of stock options, as option exercises were net settled in IHC shares. As part of the net-share settlements in 2017, cash outflows to satisfy employees’ income tax withholding obligations amounted to $303,000. Stock options exercised in 2017 had an aggregate intrinsic value of $621,000 and IHC realized $180,000 of tax benefits. The following table summarizes information regarding IHC’s outstanding and exercisable options: September 30, 2018 Outstanding Exercisable Number of options 668,947 363,612 Weighted average exercise price per share $ 17.28 $ 10.99 Aggregate intrinsic value for all options (in thousands) $ 12,458 $ 9,057 Weighted average contractual term remaining 2.2 years 0.8 years At September 30, 2018, the total unrecognized compensation cost related to IHC’s non-vested stock options was $1,473,000 and it is expected to be recognized as compensation expense over a weighted average period of 1.7 years. Restricted Stock No. Of Weighted-Average Non-vested Grant-Date Shares Fair Value December 31, 2017 18,975 $ 22.91 Vested (2,475) 11.78 September 30, 2018 16,500 $ 24.58 unit awards was $269,000 and is expected to be recognized as compensation expense over a weighted average period of 1.7 years. SARs IHC had 64,900 SAR awards outstanding at both September 30, 2018 and December 31, 2017 with corresponding liabilities of $240,000 and $22,000 for those periods, respectively, that are included in Other Liabilities in the Company’s Condensed Consolidated Balance Sheets. |
Cash Flow, Supplemental Disclos
Cash Flow, Supplemental Disclosures [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Cash Flow, Supplemental Disclosures | Note 12. Supplemental Disclosures of Cash Flow Information Net cash payments for income taxes were $1,169,000 and $292,000 during the nine months ended September 30, 2018 and 2017. |
Commitments and Contingencies D
Commitments and Contingencies Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Commitments and Contingencies Disclosure | Note 13. Contingencies A third party administrator with whom we formerly did business (“Plaintiff” or “TPA”)) filed a Complaint dated May 17, 2017 in the United States District Court, Northern District of Texas, Dallas Division, naming IHC, Madison National Life, Standard Security Life, and IHC Carrier Solutions, Inc. (collectively referred to as “Defendants”). “Plaintiff” and “Defendants” are collectively referred to herein as the “Parties”. The Complaint concerns agreements entered into by Standard Security Life and Madison National Life with Plaintiff, as well as other allegations made by Plaintiff against Defendants. The Complaint seeks injunctive relief and damages in an amount exceeding $50,000,000, profit share payments allegedly owed to Plaintiff under the agreements totaling at least $3,082,000 through 2014, plus additional amounts for 2015 and 2016, and exemplary and punitive damages as allowed by law and fees and costs. Defendants believe these claims to be without merit. Defendants moved to Compel Arbitration and Dismiss or Stay the original Complaint. Plaintiff filed an Amended Complaint on August 18, 2017. Defendants filed a Motion to Compel Arbitration or Stay the Amended Complaint. The Parties agreed to enter into an Order staying the action filed in Texas. The Parties’ disputed claims have moved in part to arbitration. Standard Security Life and Madison National Life will strongly pursue their claims and vigorously oppose the counterclaims asserted by the TPA. The arbitration will likely conclude in the first half of 2019. |
Segment Reporting Disclosure _T
Segment Reporting Disclosure [Text Block] | 9 Months Ended |
Sep. 30, 2018 | |
Notes | |
Segment Reporting Disclosure | Note 14. Segment Reporting The Insurance Group principally engages in the life and health insurance business. Interest expense, taxes, and general expenses associated with parent company activities are included in Corporate. Identifiable assets by segment are those assets that are utilized in each segment and are allocated based upon the mean reserves and liabilities of each such segment. Corporate assets are composed principally of cash equivalents, resale agreements, fixed maturities, equity securities, partnership interests and certain other investments. Effective January 1, 2018, Standard Security Life began selling a new rider (“Paid Family Leave” or “PFL”) as part of our New York short-term disability (“DBL”) policies. Information by business segment is presented below for the periods indicated (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Revenues: Specialty Health $ 53,108 $ 55,502 $ 152,959 $ 152,292 Group disability, life, DBL and PFL 35,599 26,112 107,280 78,985 Individual life, annuities and other (A) 520 455 1,432 1,494 Medical Stop-Loss (A) 13 576 36 2,549 Corporate 678 392 1,755 1,522 89,918 83,037 263,462 236,842 Net investment gains (losses) 17 715 (335) 987 Total revenues $ 89,935 $ 83,752 $ 263,127 $ 237,829 Income before income taxes Specialty Health (B) $ 10,595 $ 5,238 $ 23,319 $ 9,412 Group disability, life, DBL and PFL 4,267 5,144 14,912 12,777 Individual life, annuities and other (A) (C) (63) (385) (357) (532) Medical Stop-Loss (A) (64) (538) 100 2,752 Corporate (1,849) (2,295) (6,188) (6,042) 12,886 7,164 31,786 18,367 Net investment gains (losses) 17 715 (335) 987 Income before income taxes $ 12,903 $ 7,879 $ 31,451 $ 19,354 (A) (B) (C) |
Organization, Consolidation, _2
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Basis of Accounting, Policy [Policy Text Block] (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Policies | |
Basis of Accounting, Policy | The unaudited Condensed Consolidated Financial Statements have been prepared in conformity with U.S. generally accepted accounting principles ("GAAP") for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X and, therefore, do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements; and (ii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The condensed consolidated results of operations for the three months and nine months ended September 30, 2018 are not necessarily indicative of the results to be anticipated for the entire year. |
Organization, Consolidation, _3
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Reclassification, Policy [Policy Text Block] (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Policies | |
Reclassification, Policy | Certain amounts in prior year’s consolidated financial statements and Notes thereto have been reclassified to conform to the 2018 presentation primarily as a result of new accounting principles adopted in the current year. |
Organization, Consolidation, _4
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: Revenue Recognition, Policy (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Policies | |
Revenue Recognition, Policy | Fee income includes fees and commissions for various sales, marketing and administrative services provided by our marketing and administrative companies. Revenue is recognized as these services are performed. For these administrative service and other contracts, we have no material contract assets or contract liabilities on our consolidated balance sheet at September 30, 2018. Revenue recognized from performance obligations related to prior periods, and revenue expected to be recognized in future periods related to unfulfilled contractual performance obligations and contracts with variable consideration, is not material. |
Organization, Consolidation, _5
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Policies | |
New Accounting Pronouncements, Policy | In January 2016, the FASB issued guidance that eliminates the requirement to classify equity securities with readily determinable fair values as trading or available-for-sale. The guidance requires equity securities, other than those that result in consolidation or are accounted for under the equity method (including other ownership interests, such as partnerships, unincorporated joint ventures, and limited liability companies), to be measured at fair value with changes in the fair value recognized through net income, simplifies the impairment assessment of equity securities without readily determinable fair values and requires changes in disclosure requirements. The amendments in this guidance were applied by means of a cumulative-effect adjustment of $340,000 credit to retained earnings as of January 1, 2018. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) will be applied prospectively to equity investments that existed as of January 1, 2018. The adoption of this guidance did not have a material effect on the Company’s Consolidated Balance Sheet or IHC’s stockholders’ equity. In May 2014, the FASB issued revenue recognition guidance for entities that either enter into contracts with customers to transfer goods or services or enter into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards such as insurance contracts or lease contracts. The amendment provides specific steps that an entity should apply in order to achieve its main objective which is recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Substantially all of the Company’s revenue sources are excluded from the scope of the standard. For those revenue sources within the scope of the standard (included in the Fee income line of the Condensed Consolidated Statement of Income), there were no material changes in the timing or measurement of revenues. The amendments in this guidance were applied retrospectively with a cumulative effect adjustment on January 1, 2018, and as such, the Company recorded $552,000 of contract assets and $1,094,000 of deferred revenues, which are included on the Condensed Consolidated Balance Sheet in other assets and accounts payable, accruals and other liabilities. The overall net impact on retained earnings was a charge of $306,000, after the effects of taxes and noncontrolling interests. Recently Issued Accounting Standards Not Yet Adopted In August 2018, the FASB issued guidance to improve existing measurements, presentation and disclosure requirements for long-duration contracts issued by insurance entities. The amendments in this guidance requires an entity to (1) review and update assumptions used to measure cash flows at least annually as well as update the discount rate assumption at each reporting date; (2) measure market risk benefits associated with deposit contracts at fair value; (3) disclose liability rollforwards and information about significant inputs, judgements assumptions, and methods used in measurement. Additionally, it simplifies the amortization of deferred acquisition costs and other balances on a constant level basis over the expected term of the related contracts. The amendments in this guidance are effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. Upon adoption, the amendments in this guidance should be applied to contracts in-force as of the beginning of the earliest period presented with a cumulative adjustment to beginning retained earnings. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In August 2018, the FASB issued guidance to improve the effectiveness of disclosures in the notes to financial statements regarding fair value measurements. The amendments in this guidance are effective for all entities for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year. Certain amendments should be applied prospectively for the most recent interim or annual period presented in the initial fiscal year of adoption while other amendments should be applied retrospectively to all periods presented upon the effective date. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In July 2018, the FASB issued guidance to simplify several aspects of accounting for nonemployee share-based compensation. The amendments in this guidance are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In March 2017, the FASB issued guidance requiring premium amortization on callable debt securities to be amortized to the earliest call date to more closely align the amortization period with expectations incorporated in market pricing of the underlying securities. The amendments in this guidance should be applied using a modified retrospective approach for annual periods beginning after December 15, 2018, including interim periods within those periods. Additional disclosures are required in the period of adoption. Early adoption is permitted. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In January 2017, the FASB issued guidance to simplify the test for goodwill impairment by eliminating Step 2 in the goodwill impairment test. Instead, under the amendments in this guidance, an entity should perform its annual or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. The amendments in this guidance are effective for public business entities for annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated financial statements. In June 2016, the FASB issued guidance requiring financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. An allowance for credit losses will be deducted from the amortized cost basis to present the net carrying value at the amount expected to be collected with changes in the allowance recorded in earnings. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than the currently applied U.S. GAAP method of taking a permanent impairment of the security, which would be limited to the amount by which fair value is below the amortized cost. Certain existing requirements used to evaluate credit losses have been removed. For public entities that are SEC filers, the amendments in this guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Early adoption is permitted for fiscal years beginning after December 15, 2018. The amendments in this guidance should be applied through a cumulative effect adjustment to retained earnings upon adoption as of the beginning of the first reporting period in which the guidance is effective. Management is evaluating the requirements and potential impact that the adoption of this guidance will have on the Company’s consolidated financial statements. In February 2016, the FASB issued guidance that requires lessees to recognize the assets and liabilities that arise from leases, including operating leases, on the statement of financial position. The amendments in this guidance are effective for fiscal years beginning after December 31, 2018, including interim periods within those fiscal years. In July 2018, the FASB issued additional guidance that allows entities the option to either recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption or to use a modified retrospective approach. The Company is in the process of analyzing its lease portfolio. This process includes the evaluation of policies, processes and internal controls that will be required to comply with this new guidance. The Company plans to elect the practical expedients permitted within the new standard, which among other things, allows us to carryforward the historical lease classification. In addition, the Company plans to select the new transition method and apply the new lease requirements in the period of adoption without adjustment to the financial statements for periods prior to adoption. The Company expects the adoption of this new standard to result in an increase on its consolidated balance sheet for right-of-use assets and corresponding lease liabilities. The adoption of this guidance is not expected to have a material effect on the Company’s consolidated results of operations or cash flows. |
Fair Value Disclosures _Text _2
Fair Value Disclosures [Text Block]: Fair Value Transfer, Policy (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Policies | |
Fair Value Transfer, Policy | It is the Company’s policy to recognize transfers of assets and liabilities between levels of the fair value hierarchy at the end of a reporting period. The Company does not transfer out of Level 3 and into Level 2 until such time as observable inputs become available and reliable or the range of available independent prices narrow. The Company did not transfer any securities between Level 1, Level 2 or Level 3 in either 2018 or 2017. |
Cash and Cash Equivalents Dis_2
Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Schedule of Cash and Cash Equivalents | September 30, 2018 2017 Cash and cash equivalents $ 25,620 $ 26,565 Restricted cash included in other assets 4,791 5,884 Total cash, cash equivalents and restricted cash $ 30,411 $ 32,449 |
Investments in Debt and Marke_2
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Debt Securities, Available-for-sale | September 30, 2018 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 200,252 $ 537 $ (6,882) $ 193,907 CMOs – residential (1) 6,266 2 (388) 5,880 U.S. Government obligations 48,857 - (730) 48,127 Agency MBS – residential (2) 6 - - 6 GSEs (3) 9,566 - (347) 9,219 States and political subdivisions 173,109 129 (7,186) 166,052 Foreign government obligations 4,081 - (119) 3,962 Redeemable preferred stocks 5,970 - (173) 5,797 Total fixed maturities $ 448,107 $ 668 $ (15,825) $ 432,950 December 31, 2017 GROSS GROSS AMORTIZED UNREALIZED UNREALIZED FAIR COST GAINS LOSSES VALUE FIXED MATURITIES AVAILABLE-FOR-SALE: Corporate securities $ 148,996 $ 298 $ (2,847) $ 146,447 CMOs - residential (1) 6,857 - (180) 6,677 U.S. Government obligations 85,510 - (396) 85,114 Agency MBS - residential (2) 14 - - 14 GSEs (3) 9,887 - (205) 9,682 States and political subdivisions 182,664 598 (3,619) 179,643 Foreign government obligations 4,227 13 (90) 4,150 Redeemable preferred stocks 10,006 179 - 10,185 Total fixed maturities $ 448,161 $ 1,088 $ (7,337) $ 441,912 (1) (2) (3) |
Investments in Debt and Marke_3
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Investments Classified by Contractual Maturity Date | AMORTIZED FAIR COST VALUE Due in one year or less $ 27,898 $ 27,734 Due after one year through five years 174,430 170,503 Due after five years through ten years 138,042 132,762 Due after ten years 91,899 86,846 Fixed maturities with no single maturity date 15,838 15,105 $ 448,107 $ 432,950 |
Investments in Debt and Marke_4
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | September 30, 2018 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 98,623 $ 2,949 $ 88,261 $ 3,933 $ 186,884 $ 6,882 CMOs - residential 859 57 5,106 331 5,965 388 U.S. Government obligations 39,740 328 8,388 402 48,128 730 GSEs - - 9,318 347 9,318 347 States and political subdivisions 59,619 1,753 99,307 5,433 158,926 7,186 Foreign government obligations 1,145 12 2,816 107 3,961 119 Redeemable preferred stocks 5,797 173 - - 5,797 173 Fixed maturities in an unrealized loss position $ 205,783 $ 5,272 $ 213,196 $ 10,553 $ 418,979 $ 15,825 Number of fixed maturities in an unrealized loss position 99 96 195 December 31, 2017 Less than 12 Months 12 Months or Longer Total Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses Corporate securities $ 85,642 $ 1,250 $ 44,640 $ 1,597 $ 130,282 $ 2,847 CMOs - residential 1,381 45 5,237 135 6,618 180 U.S. Government obligations 75,811 198 9,302 198 85,113 396 GSEs - - 9,669 205 9,669 205 States and political subdivisions 83,682 1,348 66,617 2,271 150,299 3,619 Foreign government obligations 2,959 90 - - 2,959 90 Fixed maturities in an unrealized loss position $ 249,475 $ 2,931 $ 135,465 $ 4,406 $ 384,940 $ 7,337 Number of fixed maturities in an unrealized loss position 60 76 136 |
Investments in Debt and Marke_5
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Realized Gain (Loss) on Investments | Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Realized gains (losses): Fixed maturities available-for-sale $ (247) $ 719 $ (442) $ 1,062 Equity securities (2) - (7) - Total realized gains (losses) on debt and equity securities (249) 719 (449) 1,062 Unrealized gains (losses) on equity securities 266 (4) 114 (76) Gains (losses) on debt and equity securities 17 715 (335) 986 Gains (losses) on other investments - - - 1 Net investment gains (losses) $ 17 $ 715 $ (335) $ 987 |
Fair Value Disclosures _Text _3
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Fair Value, Assets Measured on Recurring Basis | September 30, 2018 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 193,907 $ - $ 193,907 CMOs - residential - 5,880 - 5,880 US Government obligations - 48,127 - 48,127 Agency MBS - residential - 6 - 6 GSEs - 9,219 - 9,219 States and political subdivisions - 164,300 1,752 166,052 Foreign government obligations - 3,962 - 3,962 Redeemable preferred stocks 5,797 - - 5,797 Total fixed maturities 5,797 425,401 1,752 432,950 Equity securities: Common stocks 2,691 - - 2,691 Nonredeemable preferred stocks 2,837 - - 2,837 Total equity securities 5,528 - - 5,528 Total Financial Assets $ 11,325 $ 425,401 $ 1,752 $ 438,478 December 31, 2017 Level 1 Level 2 Level 3 Total FINANCIAL ASSETS: Fixed maturities available-for-sale: Corporate securities $ - $ 146,447 $ - $ 146,447 CMOs - residential - 6,677 - 6,677 US Government obligations - 85,114 - 85,114 Agency MBS - residential - 14 - 14 GSEs - 9,682 - 9,682 States and political subdivisions - 177,767 1,876 179,643 Foreign government obligations - 4,150 - 4,150 Redeemable preferred stocks 10,185 - - 10,185 Total fixed maturities 10,185 429,851 1,876 441,912 Equity securities: Common stocks 2,490 - - 2,490 Nonredeemable preferred stocks 3,630 - - 3,630 Total equity securities 6,120 - - 6,120 Total Financial Assets $ 16,305 $ 429,851 $ 1,876 $ 448,032 |
Fair Value Disclosures _Text _4
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | Three Months Ended September 30, 2018 2017 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,794 $ 1,794 $ 1,956 $ 1,956 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (8) (8) (8) (8) Repayments and amortization of fixed maturities (34) (34) (31) (31) Sales - - - - Balance at end of period $ 1,752 $ 1,752 $ 1,917 $ 1,917 Nine Months Ended September 30, 2018 2017 States and Total States and Total Political Level 3 Political Level 3 Subdivisions Assets Subdivisions Assets Beginning balance $ 1,876 $ 1,876 $ 2,033 $ 2,033 Increases (decreases) recognized in earnings: Net investment gains - - - - Gains (losses) included in other comprehensive income (loss): Net unrealized gains (losses) (23) (23) (26) (26) Repayments and amortization of fixed maturities (101) (101) (90) (90) Sales - - - - Balance at end of period $ 1,752 $ 1,752 $ 1,917 $ 1,917 |
Fair Value Disclosures _Text _5
Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Fair Value, by Balance Sheet Grouping | September 30, 2018 December 31, 2017 Level 1 Level 2 Level 1 Level 2 Fair Fair Carrying Fair Fair Carrying Value Value Value Value Value Value FINANCIAL ASSETS: Short-term investments $ 1,047 $ - $ 1,047 $ 50 $ - $ 50 FINANCIAL LIABILITIES: Funds on deposit $ - $ 141,813 $ 141,685 $ - $ 143,702 $ 143,537 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Schedule of Finite-Lived Intangible Assets | September 30, 2018 December 31, 2017 Gross Gross Carrying Accumulated Carrying Accumulated Amount Amortization Amount Amortization Finite-lived Intangible Assets: Agent and broker relationships $ 17,253 $ 13,096 $ 17,253 $ 12,140 Domain 1,000 200 1,000 125 Software systems 780 169 780 76 Total finite-lived $ 19,033 $ 13,465 $ 19,033 $ 12,341 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Schedule of Indefinite-Lived Intangible Assets | September 30, December 31, 2018 2017 Indefinite-lived Intangible Assets: Insurance licenses $ 7,977 $ 7,977 Total indefinite-lived $ 7,977 $ 7,977 |
Liability for Future Policy B_2
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | Nine Months Ended September 30, 2018 2017 Balance at beginning of year $ 168,683 $ 219,113 Less: reinsurance recoverable 42,136 88,853 Net balance at beginning of year 126,547 130,260 Amount incurred, related to: Current year 127,544 114,795 Prior years (19,152) (9,236) Total incurred 108,392 105,559 Amount paid, related to: Current year 65,380 52,822 Prior years 49,916 56,452 Total paid 115,296 109,274 Net balance at end of period 119,643 126,545 Plus: reinsurance recoverable 38,525 43,002 Balance at end of period $ 158,168 $ 169,547 |
Specialty Health Segment Member | Health Insurance Product Line | |
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense | Specialty Health Segment Health Insurance Claims Nine Months Ended September 30, 2018 2017 Balance at beginning of year $ 32,904 $ 27,183 Less: reinsurance recoverable 762 1,179 Net balance at beginning of year 32,142 26,004 Amount incurred, related to: Current year 37,099 40,836 Prior years (8,266) 1,144 Total incurred 28,833 41,980 Amount paid, related to: Current year 14,880 13,528 Prior years 19,507 23,797 Total paid 34,387 37,325 Net balance at end of period 26,588 30,659 Plus: reinsurance recoverable 865 814 Balance at end of period $ 27,453 $ 31,473 |
Stockholders' Equity Note Dis_2
Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Schedule of Accumulated Other Comprehensive Income (Loss) | Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Beginning balance $ (11,237) $ (2,504) $ (4,598) $ (6,964) Cumulative-effect of new accounting principles - - (350) - Other comprehensive income (loss): Other comprehensive income (loss) before reclassifications (922) 627 (7,364) 5,305 Amounts reclassified from accumulated OCI 196 (467) 349 (685) Net other comprehensive income (loss) (726) 160 (7,015) 4,620 Ending balance $ (11,963) $ (2,344) $ (11,963) $ (2,344) |
Stockholders' Equity Note Dis_3
Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Reclassification out of Accumulated Other Comprehensive Income | Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Unrealized gains (losses) on available-for-sale securities reclassified during the period to the following income statement line items: Net investment gains (losses) $ (247) $ 719 $ (442) $ 1,062 Income (loss) before income tax (247) 719 (442) 1,062 Tax effect (51) 252 (93) 377 Net income (loss) $ (196) $ 467 $ (349) $ 685 |
Compensation and Employee Ben_2
Compensation and Employee Benefit Plans [Text Block]: Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan | Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 IHC’s Share-based Compensation Plan: Stock options $ 189 $ 36 $ 558 $ 106 Restricted stock units 39 23 129 81 SARs 93 305 218 359 Share-based compensation expense, pre-tax 321 364 905 546 Tax benefits 86 145 281 218 Share-based compensation expense, net $ 235 $ 219 $ 624 $ 328 |
Compensation and Employee Ben_3
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Stock Options, Activity (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Share-based Compensation, Stock Options, Activity | Shares Weighted- Average Under Option Exercise Price December 31, 2017 692,380 $ 16.62 Granted 13,000 31.30 Exercised (36,433) 9.79 September 30, 2018 668,947 $ 17.28 |
Compensation and Employee Ben_4
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | 2018 2017 Weighted-average risk-free interest rate 2.64% 1.71% Expected annual dividend rate per share 0.95% 0.79% Expected volatility factor of the Company's common stock 35.80% 37.57% Weighted-average expected term of options 4.5 years 4.5 years |
Compensation and Employee Ben_5
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Independence Holding Company Share Based Plans Total Member | |
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding | September 30, 2018 Outstanding Exercisable Number of options 668,947 363,612 Weighted average exercise price per share $ 17.28 $ 10.99 Aggregate intrinsic value for all options (in thousands) $ 12,458 $ 9,057 Weighted average contractual term remaining 2.2 years 0.8 years |
Compensation and Employee Ben_6
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | No. Of Weighted-Average Non-vested Grant-Date Shares Fair Value December 31, 2017 18,975 $ 22.91 Vested (2,475) 11.78 September 30, 2018 16,500 $ 24.58 |
Segment Reporting Disclosure _2
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Tables/Schedules | |
Schedule of Segment Reporting Information, by Segment | Three Months Ended Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Revenues: Specialty Health $ 53,108 $ 55,502 $ 152,959 $ 152,292 Group disability, life, DBL and PFL 35,599 26,112 107,280 78,985 Individual life, annuities and other (A) 520 455 1,432 1,494 Medical Stop-Loss (A) 13 576 36 2,549 Corporate 678 392 1,755 1,522 89,918 83,037 263,462 236,842 Net investment gains (losses) 17 715 (335) 987 Total revenues $ 89,935 $ 83,752 $ 263,127 $ 237,829 Income before income taxes Specialty Health (B) $ 10,595 $ 5,238 $ 23,319 $ 9,412 Group disability, life, DBL and PFL 4,267 5,144 14,912 12,777 Individual life, annuities and other (A) (C) (63) (385) (357) (532) Medical Stop-Loss (A) (64) (538) 100 2,752 Corporate (1,849) (2,295) (6,188) (6,042) 12,886 7,164 31,786 18,367 Net investment gains (losses) 17 715 (335) 987 Income before income taxes $ 12,903 $ 7,879 $ 31,451 $ 19,354 (A) (B) (C) |
Organization, Consolidation, _6
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] (Details) | Sep. 30, 2018 |
GeneveAffiliatedEntityMember | |
EntityCommonStockOutstandingOwnershipPercent | 62.00% |
Organization, Consolidation, _7
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]: New Accounting Pronouncements, Policy [Policy Text Block] (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Jan. 31, 2018 |
Cumulative Effect of New Accounting Principle in Period of Adoption | $ (413) | |
Accounting Standards Update 2014-09 | Other Assets | ||
Contract with Customer, Asset, Net | $ 552 | |
Accounting Standards Update 2014-09 | Accounts Payable and Accrued Liabilities | ||
Contract with Customer, Liability | 1,094 | |
Retained Earnings | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | $ 34 | |
Retained Earnings | Accounting Standards Update 2016-01 | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | 340 | |
Retained Earnings | Accounting Standards Update 2014-09 | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | $ (306) |
Earnings Per Share _Text Bloc_2
Earnings Per Share [Text Block] (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Details | ||||
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 314 | 309 | 296 | 288 |
Cash and Cash Equivalents Dis_3
Cash and Cash Equivalents Disclosure: Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 | Sep. 30, 2017 | Dec. 31, 2016 |
Cash and Cash Equivalents, at Carrying Value | $ 25,620 | $ 26,465 | $ 26,565 | |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 30,411 | $ 32,197 | 32,449 | $ 23,718 |
Other Assets | ||||
Restricted Cash | $ 4,791 | $ 5,884 |
Investments in Debt and Marke_6
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Debt Securities, Available-for-sale [Table Text Block] (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Debt Securities, Available-for-sale, Amortized Cost | $ 448,107 | $ 448,161 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 668 | 1,088 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 15,825 | 7,337 |
Debt Securities, Available-for-sale | 432,950 | 441,912 |
Corporate Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 200,252 | 148,996 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 537 | 298 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 6,882 | 2,847 |
Debt Securities, Available-for-sale | 193,907 | 146,447 |
Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 6,266 | 6,857 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 2 | 0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 388 | 180 |
Debt Securities, Available-for-sale | 5,880 | 6,677 |
US Treasury Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 48,857 | 85,510 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 730 | 396 |
Debt Securities, Available-for-sale | 48,127 | 85,114 |
US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 6 | 14 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 0 | 0 |
Debt Securities, Available-for-sale | 6 | 14 |
US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 9,566 | 9,887 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 0 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 347 | 205 |
Debt Securities, Available-for-sale | 9,219 | 9,682 |
US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale, Amortized Cost | 173,109 | 182,664 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 129 | 598 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 7,186 | 3,619 |
Debt Securities, Available-for-sale | 166,052 | 179,643 |
Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale, Amortized Cost | 4,081 | 4,227 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 13 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 119 | 90 |
Debt Securities, Available-for-sale | 3,962 | 4,150 |
Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale, Amortized Cost | 5,970 | 10,006 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 0 | 179 |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | 173 | 0 |
Debt Securities, Available-for-sale | $ 5,797 | $ 10,185 |
Investments in Debt and Marke_7
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Investments Classified by Contractual Maturity Date (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Details | ||
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost | $ 27,898 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value | 27,734 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost | 174,430 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value | 170,503 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost | 138,042 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Fair Value | 132,762 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Amortized Cost | 91,899 | |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after 10 Years, Fair Value | 86,846 | |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost | 15,838 | |
Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value | 15,105 | |
Debt Securities, Available-for-sale, Amortized Cost | 448,107 | $ 448,161 |
Debt Securities, Available-for-sale | $ 432,950 | $ 441,912 |
Investments in Debt and Marke_8
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value (Details) $ in Thousands | Sep. 30, 2018USD ($) | Dec. 31, 2017USD ($) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $ 205,783 | $ 249,475 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 5,272 | 2,931 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 213,196 | 135,465 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 10,553 | 4,406 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 418,979 | 384,940 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $ 15,825 | $ 7,337 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | 99 | 60 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | 96 | 76 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | 195 | 136 |
Corporate Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $ 98,623 | $ 85,642 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 2,949 | 1,250 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 88,261 | 44,640 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 3,933 | 1,597 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 186,884 | 130,282 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 6,882 | 2,847 |
Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 859 | 1,381 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 57 | 45 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 5,106 | 5,237 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 331 | 135 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 5,965 | 6,618 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 388 | 180 |
US Treasury Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 39,740 | 75,811 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 328 | 198 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 8,388 | 9,302 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 402 | 198 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 48,128 | 85,113 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 730 | 396 |
US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 0 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 0 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 9,318 | 9,669 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 347 | 205 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 9,318 | 9,669 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 347 | 205 |
US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 59,619 | 83,682 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 1,753 | 1,348 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 99,307 | 66,617 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 5,433 | 2,271 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 158,926 | 150,299 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 7,186 | 3,619 |
Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 1,145 | 2,959 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 12 | 90 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 2,816 | 0 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 107 | 0 |
Debt Securities, Available-for-sale, Unrealized Loss Position | 3,961 | 2,959 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | 119 | $ 90 |
Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 5,797 | |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | 173 | |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 0 | |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | 0 | |
Debt Securities, Available-for-sale, Unrealized Loss Position | 5,797 | |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $ 173 |
Investments in Debt and Marke_9
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]: Realized Gain (Loss) on Investments (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Details | ||||
Debt Securities, Available-for-sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment | $ (247) | $ 719 | $ (442) | $ 1,062 |
Equity Securities, FV-NI, Realized Gain (Loss) | (2) | 0 | (7) | 0 |
Debt and Equity Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment | (249) | 719 | (449) | 1,062 |
Equity Securities, FV-NI, Unrealized Gain (Loss) | 266 | (4) | 114 | (76) |
Debt and Equity Securities, Gain (Loss) | 17 | 715 | (335) | 986 |
Gain (Loss) on Sale of Other Investments | 0 | 0 | 0 | 1 |
Gain (Loss) on Investments | $ 17 | $ 715 | $ (335) | $ 987 |
Investments in Debt and Mark_10
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Details | ||||
Available-for-sale Securities, Gross Realized Gains | $ 130 | $ 780 | $ 449 | $ 2,119 |
Available-for-sale Securities, Gross Realized Losses | $ 377 | $ 61 | $ 891 | $ 1,057 |
Fair Value Disclosures _Text _6
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Debt Securities, Available-for-sale | $ 432,950 | $ 441,912 |
Equity Securities, FV-NI | 5,528 | 6,120 |
Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 193,907 | 146,447 |
Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 5,880 | 6,677 |
US Treasury Securities | ||
Debt Securities, Available-for-sale | 48,127 | 85,114 |
US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 6 | 14 |
US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 9,219 | 9,682 |
US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 166,052 | 179,643 |
Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 3,962 | 4,150 |
Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale | 5,797 | 10,185 |
Fair Value, Measurements, Recurring | ||
Debt Securities, Available-for-sale | 432,950 | 441,912 |
Equity Securities, FV-NI | 5,528 | 6,120 |
Assets, Fair Value Disclosure | 438,478 | 448,032 |
Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 193,907 | 146,447 |
Fair Value, Measurements, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 5,880 | 6,677 |
Fair Value, Measurements, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 48,127 | 85,114 |
Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 6 | 14 |
Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 9,219 | 9,682 |
Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 166,052 | 179,643 |
Fair Value, Measurements, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 3,962 | 4,150 |
Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale | 5,797 | 10,185 |
Fair Value, Measurements, Recurring | Common Stock | ||
Equity Securities, FV-NI | 2,691 | 2,490 |
Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Equity Securities, FV-NI | 2,837 | 3,630 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | ||
Debt Securities, Available-for-sale | 5,797 | 10,185 |
Equity Securities, FV-NI | 5,528 | 6,120 |
Assets, Fair Value Disclosure | 11,325 | 16,305 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale | 5,797 | 10,185 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Common Stock | ||
Equity Securities, FV-NI | 2,691 | 2,490 |
Fair Value, Inputs, Level 1 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Equity Securities, FV-NI | 2,837 | 3,630 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | ||
Debt Securities, Available-for-sale | 425,401 | 429,851 |
Equity Securities, FV-NI | 0 | 0 |
Assets, Fair Value Disclosure | 425,401 | 429,851 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 193,907 | 146,447 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 5,880 | 6,677 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 48,127 | 85,114 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 6 | 14 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 9,219 | 9,682 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 164,300 | 177,767 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 3,962 | 4,150 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Common Stock | ||
Equity Securities, FV-NI | 0 | 0 |
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Equity Securities, FV-NI | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | ||
Debt Securities, Available-for-sale | 1,752 | 1,876 |
Equity Securities, FV-NI | 0 | 0 |
Assets, Fair Value Disclosure | 1,752 | 1,876 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Corporate Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Collateralized Mortgage Backed Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US Treasury Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US Government Agencies Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US Government-sponsored Enterprises Debt Securities | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | US States and Political Subdivisions Debt Securities | ||
Debt Securities, Available-for-sale | 1,752 | 1,876 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Debt Security, Government, Non-US | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Redeemable Preferred Stock | ||
Debt Securities, Available-for-sale | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Common Stock | ||
Equity Securities, FV-NI | 0 | 0 |
Fair Value, Inputs, Level 3 | Fair Value, Measurements, Recurring | Nonredeemable Preferred Stock | ||
Equity Securities, FV-NI | $ 0 | $ 0 |
Fair Value Disclosures _Text _7
Fair Value Disclosures [Text Block]: Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance | $ 1,794 | $ 1,956 | $ 1,876 | $ 2,033 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (8) | (8) | (23) | (26) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (34) | (31) | (101) | (90) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales | 0 | 0 | 0 | 0 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance | 1,752 | 1,917 | 1,752 | 1,917 |
Gain (Loss) on Investments | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | 0 | 0 | 0 | 0 |
US States and Political Subdivisions Debt Securities | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Beginning Balance | 1,794 | 1,956 | 1,876 | 2,033 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) | (8) | (8) | (23) | (26) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements | (34) | (31) | (101) | (90) |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales | 0 | 0 | 0 | 0 |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value, Ending Balance | 1,752 | 1,917 | 1,752 | 1,917 |
US States and Political Subdivisions Debt Securities | Gain (Loss) on Investments | ||||
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings | $ 0 | $ 0 | $ 0 | $ 0 |
Fair Value Disclosures _Text _8
Fair Value Disclosures [Text Block]: Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Short-term Investments | $ 1,047 | $ 50 |
Deposit Contracts, Liabilities | 141,685 | 143,537 |
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 1 | ||
Short-term Investments | 1,047 | 50 |
Deposit Contracts, Liabilities | 0 | 0 |
Estimate of Fair Value Measurement | Fair Value, Inputs, Level 2 | ||
Short-term Investments | 0 | 0 |
Deposit Contracts, Liabilities | 141,813 | 143,702 |
Reported Value Measurement | ||
Short-term Investments | 1,047 | 50 |
Deposit Contracts, Liabilities | $ 141,685 | $ 143,537 |
Variable Interest Entity Disc_2
Variable Interest Entity Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Income (Loss) from Equity Method Investments | $ (976) | $ 1,412 | |||
Other Investments | Variable Interest Entity, Not Primary Beneficiary, Aggregated Disclosure | |||||
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | $ 4,131 | 4,131 | |||
Ebix Health Exchange Member | Selling, General and Administrative Expenses | |||||
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | 1,796 | $ 2,613 | 6,269 | 8,017 | |
Ebix Health Exchange Member | Other Assets | |||||
Due from Related Parties | 1,886 | 1,886 | $ 1,859 | ||
Ebix Health Exchange Member | Accounts Payable and Accrued Liabilities | |||||
Due to Related Parties | 1,086 | 1,086 | 1,139 | ||
Ebix Health Exchange Holdings Member | |||||
Equity Method Investments | 6,973 | 6,973 | $ 8,188 | ||
Income (Loss) from Equity Method Investments | $ (445) | $ (19) | $ (1,216) | $ 228 |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Details | |||||
Goodwill | $ 50,697 | $ 50,697 | $ 50,697 | ||
Intangible Assets, Net (Excluding Goodwill) | 13,545 | 13,545 | $ 14,669 | ||
Amortization of Intangible Assets | $ 381 | $ 393 | $ 1,124 | $ 941 |
Goodwill and Intangible Asset_5
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Finite-Lived Intangible Assets, Gross | $ 19,033 | $ 19,033 |
Finite-Lived Intangible Assets, Accumulated Amortization | 13,465 | 12,341 |
Customer Relationships | ||
Finite-Lived Intangible Assets, Gross | 17,253 | 17,253 |
Finite-Lived Intangible Assets, Accumulated Amortization | 13,096 | 12,140 |
Internet Domain Names | ||
Finite-Lived Intangible Assets, Gross | 1,000 | 1,000 |
Finite-Lived Intangible Assets, Accumulated Amortization | 200 | 125 |
Computer Software, Intangible Asset | ||
Finite-Lived Intangible Assets, Gross | 780 | 780 |
Finite-Lived Intangible Assets, Accumulated Amortization | $ 169 | $ 76 |
Goodwill and Intangible Asset_6
Goodwill and Intangible Assets Disclosure [Text Block]: Schedule of Indefinite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Indefinite-lived Intangible Assets (Excluding Goodwill) | $ 7,977 | $ 7,977 |
Licensing Agreements | ||
Indefinite-lived Intangible Assets (Excluding Goodwill) | $ 7,977 | $ 7,977 |
Income Tax Disclosure _Text B_2
Income Tax Disclosure [Text Block] (Details) | 6 Months Ended | 9 Months Ended |
Jun. 30, 2018 | Sep. 30, 2018 | |
Details | ||
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | 21.00% | |
Effective Income Tax Rate Reconciliation, Newly Enacted Federal Statutory Income Tax Rate, Fiscal Year Blended Rate, Percent | 28.00% |
Liability for Future Policy B_3
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]: Schedule of Liability for Unpaid Claims and Claims Adjustment Expense (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Liability for Claims and Claims Adjustment Expense, Beginning Balance | $ 168,683 | $ 219,113 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 42,136 | 88,853 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 126,547 | 130,260 |
Current Year Claims and Claims Adjustment Expense | 127,544 | 114,795 |
Prior Year Claims and Claims Adjustment Expense | (19,152) | (9,236) |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 108,392 | 105,559 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 65,380 | 52,822 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 49,916 | 56,452 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 115,296 | 109,274 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 119,643 | 126,545 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 38,525 | 43,002 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | 158,168 | 169,547 |
Specialty Health Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (9,729) | 1,304 |
Specialty Health Segment Member | Health Insurance Product Line | ||
Liability for Claims and Claims Adjustment Expense, Beginning Balance | 32,904 | 27,183 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Beginning Balance | 762 | 1,179 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Beginning Balance | 32,142 | 26,004 |
Current Year Claims and Claims Adjustment Expense | 37,099 | 40,836 |
Prior Year Claims and Claims Adjustment Expense | (8,266) | 1,144 |
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | 28,833 | 41,980 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year | 14,880 | 13,528 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years | 19,507 | 23,797 |
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid | 34,387 | 37,325 |
Liability for Unpaid Claims and Claims Adjustment Expense, Net, Ending Balance | 26,588 | 30,659 |
Reinsurance Recoverable for Unpaid Claims and Claims Adjustments, Ending Balance | 865 | 814 |
Liability for Claims and Claims Adjustment Expense, Ending Balance | $ 27,453 | $ 31,473 |
Liability for Future Policy B_4
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Prior Year Claims and Claims Adjustment Expense | $ (19,152) | $ (9,236) |
Specialty Health Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (9,729) | 1,304 |
Specialty Health Segment Member | Health Insurance Product Line | ||
Prior Year Claims and Claims Adjustment Expense | (8,266) | 1,144 |
Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net | 27,453 | |
Group Disability, Life, DBL And PFL Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (7,862) | (5,406) |
Individual life annuities and other Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | (1,346) | (2,714) |
Medical Stop-Loss Segment Member | ||
Prior Year Claims and Claims Adjustment Expense | $ (215) | $ (2,420) |
Stockholders' Equity Note Dis_4
Stockholders' Equity Note Disclosure [Text Block] (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Treasury Stock, Shares, Acquired | 129,521 | 2,211,629 |
Treasury Stock, Value, Acquired, Cost Method | $ 3,817 | $ 44,442 |
Treasury Stock | ||
Treasury Stock, Value, Acquired, Cost Method | $ 3,817 | |
Stock Issued During Period, Shares, Share-based Compensation, Gross | 38,908 | 12,671 |
Treasury Stock | Employee Stock Option | ||
Stock Issued During Period, Shares, Share-based Compensation, Gross | 12,671 | |
Private Placement Member | ||
Treasury Stock, Shares, Acquired | 703,000 | |
Treasury Stock, Value, Acquired, Cost Method | $ 13,975 | |
Tender Offer Member | ||
Treasury Stock, Shares, Acquired | 1,385,118 | |
Treasury Stock, Value, Acquired, Cost Method | $ 27,702 |
Stockholders' Equity Note Dis_5
Stockholders' Equity Note Disclosure [Text Block]: Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Accumulated other comprehensive income (loss) | $ (4,598) | |||
Other Comprehensive Income (Loss), Net of Tax | $ (726) | $ 160 | (7,015) | $ 4,620 |
Accumulated other comprehensive income (loss) | (11,963) | (11,963) | ||
Accumulated Net Investment Gain (Loss) Attributable to Parent | ||||
Accumulated other comprehensive income (loss) | (11,237) | (2,504) | (4,598) | (6,964) |
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | (922) | 627 | (7,364) | 5,305 |
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax | (196) | 467 | (349) | 685 |
Other Comprehensive Income (Loss), Net of Tax | (726) | 160 | (7,015) | 4,620 |
Accumulated other comprehensive income (loss) | (11,963) | (2,344) | (11,963) | (2,344) |
Accumulated Net Investment Gain (Loss) Attributable to Parent | Accounting Standards Update 2016-01 | ||||
Cumulative Effect of New Accounting Principle in Period of Adoption | $ 0 | $ 0 | $ (350) | $ 0 |
Stockholders' Equity Note Dis_6
Stockholders' Equity Note Disclosure [Text Block]: Reclassification out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Gain (Loss) on Investments | $ 17 | $ 715 | $ (335) | $ 987 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 12,903 | 7,879 | 31,451 | 19,354 |
Income Tax Expense (Benefit) | 2,860 | 2,666 | 7,518 | (5,175) |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | 10,043 | 5,213 | 23,933 | 24,529 |
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Net Investment Gain (Loss) Attributable to Parent | ||||
Gain (Loss) on Investments | (247) | 719 | (442) | 1,062 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (247) | 719 | (442) | 1,062 |
Income Tax Expense (Benefit) | (51) | 252 | (93) | 377 |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $ (196) | $ 467 | $ (349) | $ 685 |
Compensation and Employee Ben_7
Compensation and Employee Benefit Plans [Text Block] (Details) - Independence Holding Company Share Based Plans Total Member - USD ($) $ / shares in Units, $ in Thousands | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 846,300 | ||
Employee Stock Option | |||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 9.77 | $ 7.01 | |
Proceeds from Stock Options Exercised | $ 357 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | 886 | $ 621 | |
Employee Service Share-based Compensation, Tax Benefit from Exercise of Stock Options | 165 | 180 | |
Payments Related to Tax Withholding for Share-based Compensation | 303 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 1,473 | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 1 year 8 months 12 days | ||
Employee Stock Option | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||
Stock Appreciation Rights (SARs) | |||
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | 64,900 | 64,900 | |
Stock Appreciation Rights (SARs) | Accounts Payable and Accrued Liabilities | |||
Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent | $ 240 | $ 22 | |
Stock Appreciation Rights (SARs) | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period | 10 years | ||
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | ||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | 1 year 8 months 12 days | ||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $ 92 | $ 94 | |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options | $ 269 |
Compensation and Employee Ben_8
Compensation and Employee Benefit Plans [Text Block]: Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan (Details) - Independence Holding Company Share Based Plans Total Member - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense | $ 86 | $ 145 | $ 281 | $ 218 |
Allocated Share-based Compensation Expense, Net of Tax | 235 | 219 | 624 | 328 |
Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | 321 | 364 | 905 | 546 |
Employee Stock Option | Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | 189 | 36 | 558 | 106 |
Restricted Stock Units (RSUs) | Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | 39 | 23 | 129 | 81 |
Stock Appreciation Rights (SARs) | Selling, General and Administrative Expenses | ||||
Allocated Share-based Compensation Expense | $ 93 | $ 305 | $ 218 | $ 359 |
Compensation and Employee Ben_9
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Stock Options, Activity (Details) - Independence Holding Company Share Based Plans Total Member - Employee Stock Option | 9 Months Ended |
Sep. 30, 2018$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance | shares | 692,380 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ / shares | $ 16.62 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 13,000 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares | $ 31.30 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 36,433 |
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ / shares | $ 9.79 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance | shares | 668,947 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance | $ / shares | $ 17.28 |
Compensation and Employee Be_10
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - Independence Holding Company Share Based Plans Total Member - Employee Stock Option | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | 2.64% | 1.71% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | 0.95% | 0.79% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate | 35.80% | 37.57% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term | 4 years 6 months | 4 years 6 months |
Compensation and Employee Be_11
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding (Details) - Independence Holding Company Share Based Plans Total Member - Employee Stock Option $ / shares in Units, $ in Thousands | 9 Months Ended |
Sep. 30, 2018USD ($)$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 668,947 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 363,612 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares | $ 17.28 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | $ / shares | $ 10.99 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $ | $ 12,458 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | $ | $ 9,057 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | 2 years 2 months 12 days |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term | 9 months 18 days |
Compensation and Employee Be_12
Compensation and Employee Benefit Plans [Text Block]: Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity (Details) - Independence Holding Company Share Based Plans Total Member - Restricted Stock Units (RSUs) - $ / shares | 9 Months Ended | |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 16,500 | 18,975 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 24.58 | $ 22.91 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 2,475 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ 11.78 |
Cash Flow, Supplemental Discl_2
Cash Flow, Supplemental Disclosures [Text Block] (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Details | ||
Income Taxes Paid (Refunds), Net | $ 1,169 | $ 292 |
Commitments and Contingencies_2
Commitments and Contingencies Disclosure [Text Block] (Details) - Pending Litigation $ in Thousands | 1 Months Ended |
May 31, 2017USD ($) | |
Loss Contingency, Nature, Injunctive Relief and Damages Member | |
Loss Contingency, Damages Sought, Value | $ 50,000 |
Loss Contingency, Nature, Amounts Allegedly Owed To Plaintiff Member | |
Loss Contingency, Damages Sought, Value | $ 3,082 |
Segment Reporting Disclosure _3
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Revenues | $ 89,935 | $ 83,752 | $ 263,127 | $ 237,829 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 12,903 | 7,879 | 31,451 | 19,354 |
Amortization of Intangible Assets | 381 | 393 | 1,124 | 941 |
Operating Segments | ||||
Revenues | 89,918 | 83,037 | 263,462 | 236,842 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 12,886 | 7,164 | 31,786 | 18,367 |
Segment Reconciling Items | Gain (Loss) on Investments | ||||
Revenues | 17 | 715 | (335) | 987 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 17 | 715 | (335) | 987 |
Specialty Health Segment Member | ||||
Revenues | 53,108 | 55,502 | 152,959 | 152,292 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 10,595 | 5,238 | 23,319 | 9,412 |
Amortization of Intangible Assets | 381 | 393 | 1,124 | 941 |
Group Disability, Life, DBL And PFL Segment Member | ||||
Revenues | 35,599 | 26,112 | 107,280 | 78,985 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | 4,267 | 5,144 | 14,912 | 12,777 |
Individual life annuities and other Segment Member | ||||
Revenues | 520 | 455 | 1,432 | 1,494 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (63) | (385) | (357) | (532) |
Amortization of Other Deferred Charges | 220 | 675 | 368 | 937 |
Medical Stop-Loss Segment Member | ||||
Revenues | 13 | 576 | 36 | 2,549 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | (64) | (538) | 100 | 2,752 |
Corporate Segment | ||||
Revenues | 678 | 392 | 1,755 | 1,522 |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $ (1,849) | $ (2,295) | $ (6,188) | $ (6,042) |